<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36747883</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1997-6690</ISSN><JournalIssue CitedMedium="Print"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal fur gynakologische Endokrinologie (Osterreichische Ausg.)</Title><ISOAbbreviation>J Gynakol Endokrinol</ISOAbbreviation></Journal><ArticleTitle>[Long COVID-A New Challenge in Medicine: Focus on Pregnancy and Breastfeeding].</ArticleTitle><Pagination><StartPage>7</StartPage><EndPage>12</EndPage><MedlinePgn>7-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s41974-023-00250-5</ELocationID><Abstract><AbstractText>Long COVID (coronavirus disease) has been described as a&#xa0;new multi-organ disease, which appears to be more prevalent in women than in men. Pregnant and breastfeeding women are a&#xa0;special subgroup of patients to consider with long COVID, as only scarce data have been collected to date. Menstrual changes are commonly observed during or after COVID-19; some studies also attribute slight changes of cycle length to previous inoculation against the virus. Pregnant women who have a&#xa0;symptomatic infection with severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) are at a&#xa0;higher risk for adverse outcomes and pregnancy-associated complications. Moreover, more and robust data are required to evaluate vertical transmission. COVID vaccines are the most effective tool against the pandemic, as they prevent infection, but also appear to be able to ease long COVID symptoms. Vaccines have been proven safe and effective in both pregnant and breastfeeding women. This article aims to present current data on long COVID in pregnant and breastfeeding women and elucidate risk factors and possible treatment options.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Emilie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Abteilung f&#xfc;r Kardiologie, Universit&#xe4;tsklinik f&#xfc;r Innere Medizin II, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel 18-20, 1090 Wien, &#xd6;sterreich.</Affiliation><Identifier Source="GRID">grid.22937.3d</Identifier><Identifier Source="ISNI">0000 0000 9259 8492</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gy&#xf6;ngy&#xf6;si</LastName><ForeName>Mariann</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Abteilung f&#xfc;r Kardiologie, Universit&#xe4;tsklinik f&#xfc;r Innere Medizin II, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel 18-20, 1090 Wien, &#xd6;sterreich.</Affiliation><Identifier Source="GRID">grid.22937.3d</Identifier><Identifier Source="ISNI">0000 0000 9259 8492</Identifier></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Long COVID&#xa0;&#x2013; eine neue Herausforderung in der Medizin: Fokus auf Schwangerschaft und Stillzeit.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>J Gynakol Endokrinol</MedlineTA><NlmUniqueID>101471056</NlmUniqueID><ISSNLinking>1995-6924</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="ger"><AbstractText>Long COVID wurde als eine neue Multiorganerkrankung beschrieben, die bei Frauen h&#xe4;ufiger auftritt als bei M&#xe4;nnern. Schwangere und stillende Frauen sind eine spezielle Untergruppe von Patienten, die bei einer Long-COVID-Erkrankung zu ber&#xfc;cksichtigen sind, da bisher die Datenlage nur gering ausf&#xe4;llt. Menstruationsver&#xe4;nderungen werden h&#xe4;ufig w&#xe4;hrend oder nach einer akuten Erkrankung mit dem Coronavirus-2019 (COVID-19) beobachtet. Einige Studien stellen zudem einen Zusammenhang zwischen geringen Ver&#xe4;nderungen der Zyklusl&#xe4;nge und einer COVID-Impfung dar. Schwangere Frauen, die eine symptomatische Infektion mit dem schweren-akuten-Atemwegssyndrom-Coronavirus Typ&#xa0;2 (SARS-CoV&#x2011;2) hatten, k&#xf6;nnen ein h&#xf6;heres Risiko f&#xfc;r Komplikationen in der Schwangerschaft, wie Fr&#xfc;hgeburt oder Pr&#xe4;eklampsie, haben. Dar&#xfc;ber hinaus sind mehr Studien notwendig, um die Auswirkungen einer vertikalen &#xdc;bertragung zu beurteilen. Das wirksamste Mittel gegen die Pandemie sind die verf&#xfc;gbaren COVID-Impfstoffe, da sie eine Infektion verhindern, aber auch Long-COVID-Symptome lindern k&#xf6;nnen. Impfstoffe haben sich sowohl bei schwangeren als auch bei stillenden Frauen als sicher und wirksam erwiesen. Ziel dieses Artikels ist es, die aktuell verf&#xfc;gbaren Daten zu Long COVID bei schwangeren und stillenden Frauen darzustellen und die Risikofaktoren und therapeutischen M&#xf6;glichkeiten aufzuzeigen.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID vaccine</Keyword><Keyword MajorTopicYN="N">Lactation</Keyword><Keyword MajorTopicYN="N">Menstruation</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of COVID-19</Keyword><Keyword MajorTopicYN="N">Pregnancy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>2</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36747883</ArticleId><ArticleId IdType="pmc">PMC9893966</ArticleId><ArticleId IdType="doi">10.1007/s41974-023-00250-5</ArticleId><ArticleId IdType="pii">250</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Visco V, Vitale C, Rispoli A, Izzo C, Virtuoso N, Ferruzzi GJ, et al. Post-COVID-19 syndrome: involvement and interactions between respiratory, cardiovascular and nervous systems. J Clin Med. 2022;11(3):524&#x2013;520. doi: 10.3390/jcm11030524.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030524</ArticleId><ArticleId IdType="pmc">PMC8836767</ArticleId><ArticleId IdType="pubmed">35159974</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med. 2021 doi: 10.3389/fmed.2021.653516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.653516</ArticleId><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11(2):269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-coV-2 admitted to ICus of the Lombardy region, Italy. JAMA. 2020;323(16):1574&#x2013;1581. doi: 10.1001/jama.2020.5394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.5394</ArticleId><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez JMD, Du-Fay-de-Lavallaz JM, Fugar S, Sarau A, Simmons JA, Clark B, et al. Sex differences in COVID-19 hospitalization and mortality. J Womens Health. 2021;30(5):646&#x2013;653. doi: 10.1089/jwh.2020.8948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2020.8948</ArticleId><ArticleId IdType="pubmed">33826864</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. Female gender is associated with long COVID syndrome: a&#xa0;prospective cohort study. Clin Microbiol Infect. 2022;28(4):611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Umesh A, Pranay K, Pandey RC, Gupta MK. Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism. Infection. 2022 doi: 10.1007/s15010-022-01835-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01835-6</ArticleId><ArticleId IdType="pmc">PMC9055372</ArticleId><ArticleId IdType="pubmed">35489015</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G, Tisato V. COVID-19 and individual genetic susceptibility/receptivity: role of ACE1/ACE2 genes, immunity, inflammation and coagulation. Might the double X-chromosome in females be protective against SARS-coV-2 compared to the single X-chromosome in males? Int J Mol Sci. 2020;21(10):3474. doi: 10.3390/ijms21103474.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21103474</ArticleId><ArticleId IdType="pmc">PMC7278991</ArticleId><ArticleId IdType="pubmed">32423094</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, Fett C, Mack M, Ten EPP, Meyerholz DK, Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome Coronavirus infection. J Immunol. 1950;198(10):4046&#x2013;4053. doi: 10.4049/jimmunol.1601896.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601896</ArticleId><ArticleId IdType="pmc">PMC5450662</ArticleId><ArticleId IdType="pubmed">28373583</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechmann N, Barthel A, Schedl A, Herzig S, Varga Z, Gebhard C, et al. Sexual dimorphism in COVID-19: potential clinical and public health implications. Lancet Diabetes Endocrinol. 2022;10(3):221&#x2013;230. doi: 10.1016/S2213-8587(21)00346-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00346-6</ArticleId><ArticleId IdType="pmc">PMC8803381</ArticleId><ArticleId IdType="pubmed">35114136</ArticleId></ArticleIdList></Reference><Reference><Citation>Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel Angiotensin-converting enzyme-related Carboxypeptidase (ACE2) converts Angiotensin I to Angiotensin 1&#x2013;9. Circ Res. 2000 doi: 10.1161/01.res.87.5.e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.res.87.5.e1</ArticleId><ArticleId IdType="pubmed">10969042</ArticleId></ArticleIdList></Reference><Reference><Citation>Brojakowska A, Narula J, Shimony R, Bander J. Clinical implications of SARS-CoV-2 interaction with Renin Angiotensin system: JACC review topic of the week. J Am Coll Cardiol. 2020;75(24):3085&#x2013;3095. doi: 10.1016/j.jacc.2020.04.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.04.028</ArticleId><ArticleId IdType="pmc">PMC7161517</ArticleId><ArticleId IdType="pubmed">32305401</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama IE, Voors AA. Men more vulnerable to COVID-19: explained by ACE2 on the X chromosome? Eur Heart J. 2020;41(32):3096. doi: 10.1093/eurheartj/ehaa526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa526</ArticleId><ArticleId IdType="pmc">PMC7337767</ArticleId><ArticleId IdType="pubmed">32577762</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgendy IY, Pepine CJ. Why are women better protected from COVID-19: Clues for men? Sex and COVID-19. Int J Cardiol. 2020;315:105&#x2013;106. doi: 10.1016/j.ijcard.2020.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2020.05.026</ArticleId><ArticleId IdType="pmc">PMC7211570</ArticleId><ArticleId IdType="pubmed">32418736</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkhouli M, Nanjundappa A, Annie F, Bates MC, Bhatt DL. Sex differences in case fatality rate of COVID-19: insights from a&#xa0;multinational registry. Mayo Clin Proc. 2020;95(8):1613&#x2013;1620. doi: 10.1016/j.mayocp.2020.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.05.014</ArticleId><ArticleId IdType="pmc">PMC7256502</ArticleId><ArticleId IdType="pubmed">32753136</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgendy IY, Pepine CJ. Reply to &#x201c;Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link. Int J Cardiol. 2021;328:250. doi: 10.1016/j.ijcard.2020.11.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2020.11.058</ArticleId><ArticleId IdType="pmc">PMC7687356</ArticleId><ArticleId IdType="pubmed">33248187</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M, Parati G, Di Dedda U, Bussotti M, Agricola E, Menicanti L, et al. When outcomes diverge: age and cardiovascular risk as determinants of mortality and ICU admission in COVID-19. J Clin Med. 2022;11(14):4099. doi: 10.3390/jcm11144099.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11144099</ArticleId><ArticleId IdType="pmc">PMC9316345</ArticleId><ArticleId IdType="pubmed">35887864</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S, et al. Long COVID, a&#xa0;comprehensive systematic scoping review. Infection. 2021;49(6):1163&#x2013;1186. doi: 10.1007/s15010-021-01666-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O&#x2019;Brien K, Sheill G, Dyer AH, O&#x2019;Kelly B, et al. Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc. 2021;18(6):997&#x2013;1003. doi: 10.1513/AnnalsATS.202009-1175OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Wastnedge EAN, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, et al. Pregnancy and COVID-19. Physiol Rev. 2021;101(1):303&#x2013;318. doi: 10.1152/physrev.00024.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00024.2020</ArticleId><ArticleId IdType="pmc">PMC7686875</ArticleId><ArticleId IdType="pubmed">32969772</ArticleId></ArticleIdList></Reference><Reference><Citation>Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi: 10.1136/bmj.m3320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3320</ArticleId><ArticleId IdType="pmc">PMC7459193</ArticleId><ArticleId IdType="pubmed">32873575</ArticleId></ArticleIdList></Reference><Reference><Citation>Defez-Martin M, Mart&#xed;n-D&#xed;az MI, Atienza-Ramirez S, Llorca-Colomer F, Murillo-Llorente MT, Perez-Bermejo M. Thrombocytopaenia and COVID-19 infection during pregnancy increases the risk of preeclampsia: a&#xa0;multicentre study. Reprod Biomed Online. 2022 doi: 10.1016/j.rbmo.2022.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbmo.2022.11.001</ArticleId><ArticleId IdType="pmc">PMC9637046</ArticleId><ArticleId IdType="pubmed">36428176</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz DA, Avvad-Portari E, Bab&#xe1;l P, Baldewijns M, Blomberg M, Bouachba A, et al. Placental tissue destruction and insufficiency from COVID-19 causes stillbirth and neonatal death from hypoxic-Ischemic injury: a study of 68 cases with SARS-coV-2 Placentitis from 12 countries. Arch Pathol Lab Med. 2022;146(6):660&#x2013;676. doi: 10.5858/arpa.2022-0029-SA.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2022-0029-SA</ArticleId><ArticleId IdType="pubmed">35142798</ArticleId></ArticleIdList></Reference><Reference><Citation> (2022) How COVID-19 can harm pregnancy and reproductive health. Science. https://www.nationalgeographic.com/science/article/how-covid-19-can-harm-pregnancy-and-reproductive-health. Zugegriffen: 30. Nov. 2022</Citation></Reference><Reference><Citation>Lebar V, Lagan&#xe0; AS, Chiantera V, Kuni&#x10d; T, Lukanovi&#x107; D. The effect of COVID-19 on the menstrual cycle: a systematic review. J Clin Med. 2022;11(13):3800. doi: 10.3390/jcm11133800.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11133800</ArticleId><ArticleId IdType="pmc">PMC9267255</ArticleId><ArticleId IdType="pubmed">35807090</ArticleId></ArticleIdList></Reference><Reference><Citation>Amer AA, Amer SA, Alrufaidi KM, Abd-Elatif EE, Alafandi BZ, Yousif DA, et al. Menstrual changes after COVID-19 vaccination and/or SARS-CoV-2 infection and their demographic, mood, and lifestyle determinants in Arab women of childbearing age, 2021. Front Reprod Health. 2022 doi: 10.3389/frph.2022.927211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/frph.2022.927211</ArticleId><ArticleId IdType="pmc">PMC9580647</ArticleId><ArticleId IdType="pubmed">36303671</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7&#xa0;months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelman A, Boniface ER, Benhar E, Han L, Matteson KA, Favaro C, et al. Association between menstrual cycle length and Coronavirus disease 2019 (COVID-19) vaccination: a U.S. Cohort. Obstet Gynecol. 2022;139(4):481&#x2013;489. doi: 10.1097/AOG.0000000000004695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000004695</ArticleId><ArticleId IdType="pmc">PMC8936155</ArticleId><ArticleId IdType="pubmed">34991109</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KMN, Junkins EJ, Luo C, Fatima UA, Cox ML, Clancy KBH. Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination. Sci Adv. 2022;8(28):eabm7201. doi: 10.1126/sciadv.abm7201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abm7201</ArticleId><ArticleId IdType="pmc">PMC9286513</ArticleId><ArticleId IdType="pubmed">35857495</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a&#xa0;longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado K, Ayuk P. Post-COVID-19 condition and pregnancy. Case Rep Womens Health. 2022 doi: 10.1016/j.crwh.2022.e00458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crwh.2022.e00458</ArticleId><ArticleId IdType="pmc">PMC9622021</ArticleId><ArticleId IdType="pubmed">36338320</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Sousa Oliveira AM, Carvalho MA, Nacul L, Cabar FR, Fabri AW, Peres SV, et al. Post-viral fatigue following SARS-CoV-2 infection during pregnancy: a&#xa0;longitudinal comparative study. Int J Environ Res Public Health. 2022 doi: 10.3390/ijerph192315735.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192315735</ArticleId><ArticleId IdType="pmc">PMC9737157</ArticleId><ArticleId IdType="pubmed">36497810</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari M, Pormohammad A, Sheikh Neshin SA, Ghorbani S, Bose D, Alimohammadi S, et al. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: a systematic review and meta-analysis. Rev Med Virol. 2021;31(5):e2208. doi: 10.1002/rmv.2208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2208</ArticleId><ArticleId IdType="pmc">PMC7883245</ArticleId><ArticleId IdType="pubmed">33387448</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, Liu J, Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(19):12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrott B, Head R, Pringle KG, Lumbers ER, Martin JH. &#x201c;LONG COVID&#x201d;-A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol Res Perspect. 2022;10(1):e00911. doi: 10.1002/prp2.911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.911</ArticleId><ArticleId IdType="pmc">PMC8929332</ArticleId><ArticleId IdType="pubmed">35029046</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27(1):28&#x2013;33. doi: 10.1038/s41591-020-01202-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosier H, Farhadian SF, Morotti RA, Deshmukh U, Lu-Culligan A, Campbell KH, et al. SARS-CoV-2 infection of the placenta. J Clin Invest. 2020;130(9):4947&#x2013;4953. doi: 10.1172/JCI139569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI139569</ArticleId><ArticleId IdType="pmc">PMC7456249</ArticleId><ArticleId IdType="pubmed">32573498</ArticleId></ArticleIdList></Reference><Reference><Citation>Algarroba GN, Rekawek P, Vahanian SA, Khullar P, Palaia T, Peltier MR, et al. Visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy. Am J Obstet Gynecol. 2020;223(2):275&#x2013;278. doi: 10.1016/j.ajog.2020.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2020.05.023</ArticleId><ArticleId IdType="pmc">PMC7219376</ArticleId><ArticleId IdType="pubmed">32405074</ArticleId></ArticleIdList></Reference><Reference><Citation>Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nature Reviews Immunology. 2017;17(8):469&#x2013;482. doi: 10.1038/nri.2017.64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.64</ArticleId><ArticleId IdType="pubmed">28627518</ArticleId></ArticleIdList></Reference><Reference><Citation>Blakeway H, Prasad S, Kalafat E, Heath PT, Ladhani SN, Le Doare K, et al. COVID-19 vaccination during pregnancy: coverage and safety. Am J Obstet Gynecol. 2022;226(2):236.e1&#x2013;236.e14. doi: 10.1016/j.ajog.2021.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2021.08.007</ArticleId><ArticleId IdType="pmc">PMC8352848</ArticleId><ArticleId IdType="pubmed">34389291</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselink AK, Hatch EE, Rothman KJ, Wang TR, Willis MD, Yland J, et al. A prospective cohort study of COVID-19 vaccination, SARS-coV-2 infection, and fertility. Am J Epidemiol. 2022;191(8):1383&#x2013;1395. doi: 10.1093/aje/kwac011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwac011</ArticleId><ArticleId IdType="pmc">PMC8807200</ArticleId><ArticleId IdType="pubmed">35051292</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazrafkan M, Hosseini E, Nazari M, Amorim CA, Sadeghi MR. NLRP3 inflammasome: a joint, potential therapeutic target in management of COVID-19 and fertility problems. J Reprod Immunol. 2021;148:103427. doi: 10.1016/j.jri.2021.103427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jri.2021.103427</ArticleId><ArticleId IdType="pmc">PMC8453780</ArticleId><ArticleId IdType="pubmed">34563758</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanchal S, Mishra A, Singh MK, Ashraf MZ. Understanding inflammatory responses in the manifestation of prothrombotic phenotypes. Front Cell Dev Biol. 2020;8:73. doi: 10.3389/fcell.2020.00073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00073</ArticleId><ArticleId IdType="pmc">PMC7033430</ArticleId><ArticleId IdType="pubmed">32117993</ArticleId></ArticleIdList></Reference><Reference><Citation>Szukiewicz D, Wojdasiewicz P, Watroba M, Szewczyk G. Mast cell activation syndrome in COVID-19 and female reproductive function: theoretical background vs. accumulating clinical evidence. J Immunol Res. 2022 doi: 10.1155/2022/9534163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/9534163</ArticleId><ArticleId IdType="pmc">PMC9242765</ArticleId><ArticleId IdType="pubmed">35785029</ArticleId></ArticleIdList></Reference><Reference><Citation> RKI &#x2013; Impfen &#x2013; Impfung bei Schwangeren, Stillenden und bei Kinderwunsch. https://www.rki.de/SharedDocs/FAQ/COVID-Impfen/FAQ_Liste_Impfung_Schwangere_Stillende.html (Erstellt: 11. Okt. 2022). Zugegriffen: 30. Nov. 2022</Citation></Reference><Reference><Citation>Pateisky P, Kiss H, Ciresa-K&#xf6;nig A, Pristauz-Telsnigg G. Booster-Impfung mittels mRNA-Impfstoffen gegen das SARS-CoV-2-Virus &#x2013; Empfehlung f&#xfc;r Schwangere und stillenden Frauen. &#xd6;sterr Ges Gyn&#xe4;kol Geburtsh. 2022;41(1):19&#x2013;20.</Citation></Reference><Reference><Citation>Robert Koch Inst . Epidemiologisches Bulletin 38/2021. 2021.</Citation></Reference><Reference><Citation>Dawood FS, Varner M, Tita A, Newes-Adeyi G, Gyamfi-Bannerman C, Battarbee A, et al. Incidence and clinical characteristics of and risk factors for severe acute respiratory syndrome Coronavirus 2 (SARS-coV-2) infection among pregnant individuals in the United States. Clin Infect Dis. 2022;74(12):2218&#x2013;2226. doi: 10.1093/cid/ciab713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab713</ArticleId><ArticleId IdType="pmc">PMC8513407</ArticleId><ArticleId IdType="pubmed">34410340</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos CAD, Fonseca Filho GG, Alves MM, Macedo EYL, de Pontes MGA, Paula AP, et al. Maternal and neonatal outcomes associated with mild COVID-19 infection in an obstetric cohort in Brazil. Am J Trop Med Hyg. 2022;107(5):1060&#x2013;1065. doi: 10.4269/ajtmh.22-0421.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.22-0421</ArticleId><ArticleId IdType="pmc">PMC9709018</ArticleId><ArticleId IdType="pubmed">36252801</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera JE, Niehaus WN, Whiteson J, Azola A, Baratta JM, Fleming TK, et al. Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients. PM R. 2021;13(9):1027&#x2013;1043. doi: 10.1002/pmrj.12684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12684</ArticleId><ArticleId IdType="pmc">PMC8441628</ArticleId><ArticleId IdType="pubmed">34346558</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>